0001505065 2026-01-01 2026-06-30 0001505065 2026-06-30 0001505065 2025-12-31 0001505065 2025-01-01 2025-06-30 0001505065 ifrs-full:IssuedCapitalMember 2025-12-31 0001505065 ifrs-full:SharePremiumMember 2025-12-31 0001505065 bway:ReserveForSharedBasedPaymentTransactionsMember 2025-12-31 0001505065 bway:CurrencyTranslationAdjustmentsMember 2025-12-31 0001505065 ifrs-full:RetainedEarningsMember 2025-12-31 0001505065 ifrs-full:IssuedCapitalMember 2024-12-31 0001505065 ifrs-full:SharePremiumMember 2024-12-31 0001505065 bway:ReserveForSharedBasedPaymentTransactionsMember 2024-12-31 0001505065 bway:CurrencyTranslationAdjustmentsMember 2024-12-31 0001505065 ifrs-full:RetainedEarningsMember 2024-12-31 0001505065 2024-12-31 0001505065 ifrs-full:IssuedCapitalMember 2026-01-01 2026-06-30 0001505065 ifrs-full:SharePremiumMember 2026-01-01 2026-06-30 0001505065 bway:ReserveForSharedBasedPaymentTransactionsMember 2026-01-01 2026-06-30 0001505065 bway:CurrencyTranslationAdjustmentsMember 2026-01-01 2026-06-30 0001505065 ifrs-full:RetainedEarningsMember 2026-01-01 2026-06-30 0001505065 ifrs-full:IssuedCapitalMember 2025-01-01 2025-06-30 0001505065 ifrs-full:SharePremiumMember 2025-01-01 2025-06-30 0001505065 bway:ReserveForSharedBasedPaymentTransactionsMember 2025-01-01 2025-06-30 0001505065 bway:CurrencyTranslationAdjustmentsMember 2025-01-01 2025-06-30 0001505065 ifrs-full:RetainedEarningsMember 2025-01-01 2025-06-30 0001505065 ifrs-full:IssuedCapitalMember 2026-06-30 0001505065 ifrs-full:SharePremiumMember 2026-06-30 0001505065 bway:ReserveForSharedBasedPaymentTransactionsMember 2026-06-30 0001505065 bway:CurrencyTranslationAdjustmentsMember 2026-06-30 0001505065 ifrs-full:RetainedEarningsMember 2026-06-30 0001505065 ifrs-full:IssuedCapitalMember 2025-06-30 0001505065 ifrs-full:SharePremiumMember 2025-06-30 0001505065 bway:ReserveForSharedBasedPaymentTransactionsMember 2025-06-30 0001505065 bway:CurrencyTranslationAdjustmentsMember 2025-06-30 0001505065 ifrs-full:RetainedEarningsMember 2025-06-30 0001505065 2025-06-30 0001505065 bway:Level2Member 2026-06-30 0001505065 bway:Leve3Member 2026-06-30 0001505065 bway:Level2Member bway:FairValueOfHierachyMember 2025-12-31 0001505065 bway:Level3Member bway:FairValueOfHierachyMember 2025-12-31 0001505065 bway:NeuroliefMember 2026-06-30 0001505065 bway:NeuroliefMember 2025-12-31 0001505065 bway:StellaMember 2026-06-30 0001505065 bway:StellaMember 2025-12-31 0001505065 bway:AxisMember 2026-06-30 0001505065 bway:AxisMember 2025-12-31 0001505065 bway:TangientMember 2026-06-30 0001505065 bway:TangientMember 2025-12-31 0001505065 bway:HopemarkMember 2026-06-30 0001505065 bway:HopemarkMember 2025-12-31 0001505065 bway:BrainStimMember 2026-06-30 0001505065 bway:BrainStimMember 2025-12-31 0001505065 bway:ActiveRecoveryMember 2026-06-30 0001505065 bway:ActiveRecoveryMember 2025-12-31 0001505065 bway:DGRMember 2026-06-30 0001505065 bway:DGRMember 2025-12-31 0001505065 bway:RadialMember 2026-06-30 0001505065 bway:RadialMember 2025-12-31 0001505065 2025-01-01 2025-12-31 0001505065 bway:DirectorsMember 2026-01-01 2026-06-30 0001505065 bway:ConsultantsMember 2026-01-01 2026-06-30 0001505065 bway:CustomerAMember 2026-01-01 2026-06-30 0001505065 bway:CustomerAMember 2025-01-01 2025-06-30 0001505065 bway:CountryOfUSAMember 2026-01-01 2026-06-30 0001505065 bway:CountryOfUSAMember 2025-01-01 2025-06-30 0001505065 bway:CountryOfAPAMember 2026-01-01 2026-06-30 0001505065 bway:CountryOfAPAMember 2025-01-01 2025-06-30 0001505065 bway:OtherMember 2026-01-01 2026-06-30 0001505065 bway:OtherMember 2025-01-01 2025-06-30 0001505065 bway:ClinicAMember 2026-01-01 2026-06-30 0001505065 bway:ClinicBMember 2026-01-01 2026-06-30 0001505065 bway:ClinicAMember 2026-06-30 0001505065 2026-07-14 0001505065 2026-07-15 0001505065 2026-08-26 iso4217:USD shares iso4217:USD shares pure 6-K 001-35165 BRAINSWAY LTD 16 Hartum Street RAD Tower 14th Floor Har HaHotzvim Jerusalem 9777516 IL false 2026-06-30 --12-31 0001505065

62108000

67700000

251000

7032000

4111000

7310000

6523000

1060000

1432000

3663000

3807000

81424000

83824000

2073000 1584000

5153000

4860000

868000 788000

5294000

5548000

2163000

1931000

25000000

14656000

40551000

29367000

121975000

113191000

2503000

2428000

10232000 10551000

1854000

1679000

1239000

1075000

6845000

6762000

22673000

22495000

9826000 6762000 4393000 5029000

5894000

5742000

20113000

17533000

0.04 0.04 120000000 120000000 40129409 40129409 39165805 39165805 440000 430000

164187000

162221000

2556000

3506000

-2188000 -2188000

-85806000

-90806000

79189000

73163000

121975000

113191000

32638000

24168000

8197000

6059000

24441000

18109000

6100000

4676000

9782000

9102000

4163000

3177000

20045000

16955000

4396000

1154000

2130000

3414000

1198000

1207000

5328000

3361000

328000

227000

5000000

3134000

0.13

0.08

0.12

0.07

430000

162221000

3506000

-2188000

-90806000

73163000

5000000

10000 1966000 -1976000

1026000

440000

164187000

2556000

-2188000

-85806000

79189000

413000

157597000

4872000

-2188000

-98381000

62313000

3134000

2000 799000 -801000 2000 -2000

559000

2126000

415000

160524000

4628000

-2188000

-95247000

68132000

5000000

3134000

406000

371000

501000 411000 -197000 168000 843000 2207000

1008000

552000

328000

227000

1203000

-478000

-237000

425000

-2921000

827000

30000

264000

729000

74000

-1690000

44000

-838000

2745000 14691000 464000 13679000

350000

54000

1285000

1748000

127000

636000

808000 1058000

7475000

17393000

-1653000 -2209000 -10125000 -5000000 -10000000 17000 7000 20000 183000 636000

-11971000

-17825000

730000 641000 326000 378000

-1056000

-1019000

-40000

18000

-5592000

-1433000

67700000

69345000

62108000

67912000

177000 197000 1487000 NOTE 1: GENERAL <table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0; margin-bottom: 0"> <tr style="vertical-align: top"> <td style="width: 24.95pt"></td> <td style="width: 17.6pt">a.</td> <td>A general description of the Company and its activity:</td></tr> </table> BrainsWay Ltd. (the “Company”) is a leader in advanced non-invasive neurostimulation treatments for mental health disorders. The Company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS™) platform technology to improve health and transform lives. The Company has obtained from the U.S. Food and Drug Administration (FDA) three cleared indications backed by pivotal studies demonstrating clinically proven efficacy. Current indications include MDD (Major Depressive Disorder), obsessive-compulsive disorder (OCD), and smoking addiction. The Company received its first commercial Deep TMS product clearance from the FDA in 2013, for the treatment of MDD in adult patients who have failed to achieve satisfactory improvement from anti-depressant medication. In April 2021, the Company received FDA clearance for a shorter innovative MDD treatment and in August 2021, the Company received an additional clearance from the FDA for expansion of the existing MDD clearance to include the non-invasive treatment of anxiety symptoms. In 2022, the Company extended its FDA clearance for MDD (including anxious depression) to the Company’s H7 Coil, also via the 510(k) process. In May 2024, the FDA cleared an expansion of the Company’s MDD clearance allowing for the treatment of patients with late life depression. The expanded clearance covers MDD patients ages 22 to 86, changing the previous upper age limit of 68. In November 2025 the FDA cleared an expanded labeling of the Company’s system to treat adolescent (ages 15-21) MDD indications as an adjunct therapy. Also in 2025, the Company obtained an expansion of its clearance to cover an accelerated treatment protocol for MDD. The Company’s Deep TMS system for MDD is currently marketed to and installed at psychiatrists’ offices and other facilities principally in the United States and in certain other countries throughout the world. The Company received de novo clearance from the FDA in August 2018 for use of its Deep TMS as an adjunct therapy for adult patients suffering from OCD, and a clearance from the FDA in August 2020 for use of its Deep TMS system as an aid in short-term smoking cessation in adults. The Company conducts activities through various wholly owned subsidiaries, including BrainsWay, Inc. (“Inc”), Brain R&D Services Ltd. (“Brain R&D”), BrainsWay USA Inc (“USA Inc”) and Tikva LLC (“Tikva”), (collectively the “Group”). Brain R&D and USA Inc. derive revenues from the sale and lease of Deep TMS systems and from related services. Tikva, a wholly owned subsidiary of Inc. formed in Delaware in 2025, makes and holds strategic investments, including in mental health services companies located in the United States and Canada. <table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0.05pt; margin-bottom: 0"> <tr style="vertical-align: top"> <td style="width: 24.9pt"></td> <td style="width: 17.65pt">b.</td> <td style="text-align: justify; padding-right: 14.15pt">The Company has a net profit of $5,000 for the six months ended June 30, 2026. The Company’s management and board of directors believe that the Company has sufficient funding to finance its business activity according to its plans in the foreseeable future.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0; margin-bottom: 0"> <tr style="vertical-align: top"> <td style="width: 24.9pt"></td> <td style="width: 17.65pt">c.</td> <td style="text-align: justify; padding-right: 14.15pt">These unaudited consolidated interim financial statements have been prepared in a condensed format as of June 30, 2026, and for the periods of six months then ended (the “interim consolidated financial statements”). The interim consolidated financial statements should be read in conjunction with the Company's audited annual consolidated financial statements as of December 31, 2025, and for the year then ended and accompanying notes (“annual consolidated financial statements”).</td></tr> </table> <table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0.05pt; margin-bottom: 0"> <tr style="vertical-align: top"> <td style="width: 24.95pt"></td> <td style="width: 17.65pt">d.</td> <td>U.S. President Trump’s tariff plan:</td></tr> </table> In April 2025, the Trump Administration announced a government plan which imposes reciprocal tariffs on the import of goods from numerous countries into the U.S. The overall tariff on the import of goods from Israel to the U.S. is 15%, effective August 2025. The tariff applies solely to the import of goods and not to the import of services. While the Company does not believe that its first half 2026 financial results were materially affected by these developments, economic uncertainty may have an impact on the Company’s market and sales in the USA. If substantial tariffs remain in place, the Company may experience a reduction in US sales and in US revenues. Although the impact of the tariffs is difficult to predict with any certainty, the Company is actively evaluating its options and potential steps that may mitigate the impact of such trade-related circumstances and the impact of trade policy changes on future results remains uncertain. <table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0.05pt; margin-bottom: 0"> <tr style="vertical-align: top"> <td style="width: 24.95pt"></td> <td style="width: 17.65pt">e.</td> <td>Effects of the war with Iran:</td></tr> </table> On February 28, 2026, Israel and the United States launched a joint military operation against strategic targets of the Iranian regime with the objective of eradicating Iran's nuclear and ballistic missile capabilities. The military operation escalated into a war in the entire region, followed by renewed armed conflict between Israel and Hizballah in Israel's northern border. During April 2026, a temporary ceasefire was agreed between Iran and Israel and the United States and thereafter (on April 17, 2026) a 10-day ceasefire between Israel and Lebanon, since then fighting has continued in southern Lebanon and Iran, involving the United States and several countries in the region. The war caused major fluctuations in energy and oil prices and in foreign exchange rates. The fluctuations in energy and oil prices and in foreign exchange rates as well as the shortage of raw materials and personnel and the inaccessibility of local services and resources are all likely to affect numerous enterprises. 5000000

NOTE 2: ACCOUNTING POLICIES Basis of presentation of the financial statements: These unaudited condensed consolidated interim financial statements (hereafter – the “consolidated interim Financial Statements”) have been prepared in accordance with IAS 34, “Interim Financial Reporting”. They do not include all of the information required for annual Financial Statements and should be read in conjunction with the consolidated Financial Statements of the Company as at and for the year ended December 31, 2025 and the accompanying notes (hereafter – the “annual consolidated financial statements”). These condensed consolidated unaudited interim Financial Statements were approved by the Board of Directors on September 28, 2026. The accounting policies applied in the preparation of these condensed consolidated unaudited interim Financial Statements are consistent with those followed in the preparation of the annual consolidated financial statements.

NOTE 3: INVENTORY Provision for impairment of inventory and system components decreased during the first half of 2026, compared with an increase during the corresponding period in 2025, primarily due to the Company’s ongoing process of identifying and disposing of obsolete inventory and the related inventory disposals carried out during the period. NOTE 4: SYSTEM COMPONENTS AND LEASED SYSTEMS, NET During the six-month periods ended June 30, 2026 and 2025, the Company acquired system components, net, totaling $1,528 and $2,100, respectively, and transferred system components to leased systems in the carrying amounts of $1,039 and $1,166, respectively.

1528000

2100000

1039000

1166000

NOTE 5: FINANCIAL INSTRUMENTS The following table presents the fair value measurement hierarchy for the Group's assets and liabilities. Quantitative disclosures of the fair value measurement hierarchy of the Group's assets and liabilities: <table cellpadding="0" cellspacing="0" id="xdx_89F_eifrs-full--DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory_pn3n3_zDYXxgkq9mZ9" style="border-collapse: collapse; width: 95%; margin-left: 24.95pt" summary="xdx: Disclosure - FINANCIAL INSTRUMENTS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Schedule of Financial instruments measured at fair value</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_497_20260630__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--Level2Member_zbnzgb3GtRw1" style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_494_20260630__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--Leve3Member_zqvo5rvBV6Gd" style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_49E_20251231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--Level2Member__ifrs-full--LevelsOfFairValueHierarchyAxis__custom--FairValueOfHierachyMember_zgNYjRYujxPk" style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_491_20251231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--Level3Member__ifrs-full--LevelsOfFairValueHierarchyAxis__custom--FairValueOfHierachyMember_zpBFoLKo04xd" style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt; text-align: center"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt; text-align: center"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt"> </td> <td colspan="6" style="font-size: 10pt; text-align: center">Fair value hierarchy</td> <td style="font-size: 10pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">June 30, 2026</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">December 31, 2025</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Level 2</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Level 3</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Level 2</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Level 3</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"> </td></tr> <tr id="xdx_408_eifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossAbstract_iB_z3VAXZf8ecxf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Assets measured at fair value:</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_40A_eifrs-full--CurrentDerivativeFinancialAssets_iI_zMeDKRzJDKga" style="vertical-align: bottom; background-color: White"> <td style="width: 48%; font-size: 10pt; text-align: left">Derivative financial instruments (a)</td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 10%; font-size: 10pt; text-align: right">1,060</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 10%; font-size: 10pt; text-align: right"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 10%; font-size: 10pt; text-align: right">1,432</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 10%; font-size: 10pt; text-align: right"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--InvestmentsInFinancialAssetsMeasuredAtFairValueThroughProfitAndLossB_iI_zYFjw4L5EHRb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Investments in financial assets measured at fair value through profit and loss (b)</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">25,000</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">14,656</td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_408_ecustom--FinancialLiabilityMeasuredAtFairValueThroughProfitAndLoss_iI_zxUoy85TRGy6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Financial liability measured at fair value through profit and loss</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">240</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">319</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0.05pt; margin-bottom: 0"> <tr style="vertical-align: top"> <td style="width: 24.95pt"></td> <td style="width: 17.65pt">a.</td> <td>Derivative financial instruments</td></tr> </table> The Company entered into several foreign currency forward contracts to protect against changes in the value of forecasted cash flow relating to salaries and related payments, service providers, and office rent expenses denominated in NIS. These contracts are designated as derivative financial instruments measured at fair value through profit or loss, in accordance with IFRS 9. During the six months periods ended June 30, 2026, and 2025, the Company recognized a gain of $646, and a loss of $1,443, respectively, on the financial investments denominated in New Israeli Shekels (NIS), due to the appreciation of ILS relative to the U.S. Dollar. The gain was recorded in profit or loss, consistent with the instrument’s classification under IFRS 9. <table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0.05pt; margin-bottom: 0"> <tr style="vertical-align: top"> <td style="width: 24.95pt"></td> <td style="width: 17.65pt">b.</td> <td style="text-align: justify">Significant investments in financial instruments are measured at fair value through profit or loss (Level 3 of fair value hierarchy), using the valuation techniques described below.</td></tr> </table> The fair value of the financial instruments is determined using a combination of valuation techniques, including Monte Carlo simulations (applied, among others, to Neurolief), including a Least Squares Monte Carlo framework applied to multi-date contractual exercise rights (applied, among others, to Neurolief), option pricing models based on a binomial framework and on a closed-form model, a market approach based on revenue or EBITDA multiples (the revenue multiple approach being applied, among others, to Neurolief, in deriving the enterprise value used in its Monte Carlo simulation), and, for investments completed shortly before the reporting date, calibration to the price of the recent transaction. The Monte Carlo simulations incorporate significant unobservable inputs such as a weighted average cost of capital (WACC) with a weighted average rate of 21.61% (primarily attributable to Neurolief, for which a WACC of 20.83% was applied), expected enterprise-value volatility assumptions ranging up to 77.85% (the upper end of the range being attributable to Neurolief, for which volatility of 77.41%-77.85% was applied) with a weighted average of 64.93% (primarily attributable to Neurolief, for which volatility of approximately 77.6% was applied, and to Stella), and a risk-free interest rate with a weighted average of 4.08% (primarily attributable to Neurolief, for which rates of 3.98%–4.15% were applied, and to Stella). The option pricing models rely on significant unobservable inputs including expected enterprise-value volatility of 46.65% and a risk-free interest rate with a weighted average of 4.24%. In addition, the market approach applies revenue multiples as a significant unobservable input, which were determined based on comparable market data and resulted in a weighted average multiple of 2.13 (primarily attributable to Neurolief, for which a multiple of 2.57x was applied, and to Stella), as well as an EV/EBITDA multiple of 6.5 applied to one investment. For that investment, a probability-weighted scenario analysis was applied, using probabilities of 59%, 40% and 1% assigned to the low, base and ideal scenarios, respectively. Changes in these assumptions could result in material changes to the fair value measurements. <table cellpadding="0" cellspacing="0" id="xdx_892_eifrs-full--DisclosureOfFinancialInstrumentsDesignatedAtFairValueThroughProfitOrLossExplanatory_zSS3ivV9sIN4" style="border-collapse: collapse; width: 95%; margin-left: 24.95pt" summary="xdx: Disclosure - FINANCIAL INSTRUMENTS (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-indent: -8.5pt; padding-left: 8.5pt">Schedule of  financial instruments are measured at fair value through profit or loss</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">June 30,</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">December 31,</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2026</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2025</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: -8.5pt; padding-left: 8.5pt">Financial assets at fair value through profit or loss:</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-indent: -8.5pt; padding-left: 8.5pt"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; font-size: 10pt; text-indent: -8.5pt; padding-left: 8.5pt">Neurolief (1)</td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td id="xdx_980_eifrs-full--FinancialAssetsAtFairValueThroughProfitOrLoss_iI_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--NeuroliefMember_zGGs286D1nKh" style="width: 12%; font-size: 10pt; text-align: right" title="Financial assets at fair value through profit or loss">11,452</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td id="xdx_984_eifrs-full--FinancialAssetsAtFairValueThroughProfitOrLoss_iI_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--NeuroliefMember_z8TSN5poQYQa" style="width: 12%; font-size: 10pt; text-align: right" title="Financial assets at fair value through profit or loss">5,366</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-indent: -8.5pt; padding-left: 8.5pt">Stella</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_983_eifrs-full--FinancialAssetsAtFairValueThroughProfitOrLoss_iI_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--StellaMember_zzu9KlCNO2la" style="font-size: 10pt; text-align: right" title="Financial assets at fair value through profit or loss">5,631</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_988_eifrs-full--FinancialAssetsAtFairValueThroughProfitOrLoss_iI_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--StellaMember_zMHUrLs8YjKl" style="font-size: 10pt; text-align: right" title="Financial assets at fair value through profit or loss">5,000</td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-indent: -8.5pt; padding-left: 8.5pt">Axis (2)</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_987_eifrs-full--FinancialAssetsAtFairValueThroughProfitOrLoss_iI_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AxisMember_zBqdNgrpMzl5" style="font-size: 10pt; text-align: right" title="Financial assets at fair value through profit or loss">2,608</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_985_eifrs-full--FinancialAssetsAtFairValueThroughProfitOrLoss_iI_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AxisMember_zUYmLbm3Wvtb" style="font-size: 10pt; text-align: right" title="Financial assets at fair value through profit or loss">2,377</td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-indent: -8.5pt; padding-left: 8.5pt">Tangient (3)</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_986_eifrs-full--FinancialAssetsAtFairValueThroughProfitOrLoss_iI_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TangientMember_zZBalP6FjvBg" style="font-size: 10pt; text-align: right" title="Financial assets at fair value through profit or loss">1,713</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_98D_eifrs-full--FinancialAssetsAtFairValueThroughProfitOrLoss_iI_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TangientMember_zqByNSzGblde" style="font-size: 10pt; text-align: right" title="Financial assets at fair value through profit or loss">1,538</td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-indent: -8.5pt; padding-left: 8.5pt">Hopemark (4)</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_985_eifrs-full--FinancialAssetsAtFairValueThroughProfitOrLoss_iI_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--HopemarkMember_zPPrdB466j84" style="font-size: 10pt; text-align: right" title="Financial assets at fair value through profit or loss">1,515</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_980_eifrs-full--FinancialAssetsAtFairValueThroughProfitOrLoss_iI_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--HopemarkMember_z3QEGnvwbWU3" style="font-size: 10pt; text-align: right" title="Financial assets at fair value through profit or loss">— </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-indent: -8.5pt; padding-left: 8.5pt">BrainStim (5)</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_989_eifrs-full--FinancialAssetsAtFairValueThroughProfitOrLoss_iI_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BrainStimMember_zOWf3fuzwWMl" style="font-size: 10pt; text-align: right" title="Financial assets at fair value through profit or loss">1,063</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_980_eifrs-full--FinancialAssetsAtFairValueThroughProfitOrLoss_iI_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BrainStimMember_zycambNI0N7i" style="font-size: 10pt; text-align: right" title="Financial assets at fair value through profit or loss">— </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: -8.5pt; padding-left: 8.5pt">Active Recovery (6)</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_985_eifrs-full--FinancialAssetsAtFairValueThroughProfitOrLoss_iI_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ActiveRecoveryMember_zKxBMwsSAcZ5" style="font-size: 10pt; text-align: right" title="Financial assets at fair value through profit or loss">500</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_983_eifrs-full--FinancialAssetsAtFairValueThroughProfitOrLoss_iI_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ActiveRecoveryMember_z2DYC06sF2m2" style="font-size: 10pt; text-align: right" title="Financial assets at fair value through profit or loss">— </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-indent: -8.5pt; padding-left: 8.5pt">DGR</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_980_eifrs-full--FinancialAssetsAtFairValueThroughProfitOrLoss_iI_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DGRMember_z19qigSocDtj" style="font-size: 10pt; text-align: right" title="Financial assets at fair value through profit or loss">268</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_98C_eifrs-full--FinancialAssetsAtFairValueThroughProfitOrLoss_iI_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DGRMember_zqgD1uJamqHf" style="font-size: 10pt; text-align: right" title="Financial assets at fair value through profit or loss">250</td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 1pt; text-indent: -8.5pt; padding-left: 8.5pt">Radial (7)</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_98F_eifrs-full--FinancialAssetsAtFairValueThroughProfitOrLoss_iI_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--RadialMember_zPAup9q5XXnl" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Financial assets at fair value through profit or loss">250</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_984_eifrs-full--FinancialAssetsAtFairValueThroughProfitOrLoss_iI_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--RadialMember_zMXymnNefnA7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Financial assets at fair value through profit or loss">125</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-indent: -8.5pt; padding-left: 8.5pt"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -8.5pt; padding-left: 8.5pt">Total financial assets at fair value through profit or loss</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_98B_eifrs-full--FinancialAssetsAtFairValueThroughProfitOrLoss_iI_c20260630_zDydJgoTz9Yh" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Financial assets at fair value through profit or loss">25,000</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_983_eifrs-full--FinancialAssetsAtFairValueThroughProfitOrLoss_iI_c20251231_z11MbzeHRd3l" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Financial assets at fair value through profit or loss">14,656</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-indent: -8.5pt; padding-left: 8.5pt"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: -8.5pt; padding-left: 8.5pt">Financial liabilities at fair value through profit or loss:</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-indent: -8.5pt; padding-left: 8.5pt"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 1pt; text-indent: -8.5pt; padding-left: 8.5pt">Neurolief (1)</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_983_eifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLoss_iNI_di_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--NeuroliefMember_zYTgMVB6nP8l" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="financial liabilities at fair value through profit or loss">(240</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_984_eifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLoss_iNI_di_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--NeuroliefMember_zhl0geMGwsx6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="financial liabilities at fair value through profit or loss">(319</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-indent: -8.5pt; padding-left: 8.5pt"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -8.5pt; padding-left: 8.5pt">Total financial liabilities at fair value through profit or loss</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_98B_eifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLoss_iNI_di_c20260630_zC4Vm27OVLi7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="financial liabilities at fair value through profit or loss">(240</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_989_eifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLoss_iNI_di_c20251231_zXcQhXTJ8Izj" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="financial liabilities at fair value through profit or loss">(319</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td></tr> </table> <table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--DisclosureOfWarrantsLiabilityExplanatory_pn3n3_zR7XctkeVto5" style="border-collapse: collapse; width: 95%; margin-left: 24.95pt" summary="xdx: Disclosure - FINANCIAL INSTRUMENTS (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right" title="Investment in financial instruments"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right" title="Investment in financial instruments"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt; font-size: 10pt; text-indent: 0pt"> </td> <td style="padding: 0pt; font-size: 10pt; text-indent: 0pt"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding: 0pt; font-size: 10pt; text-align: center; text-indent: 0pt"> For the six months ended June 30, 2026</td> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding: 0pt; font-size: 10pt; text-indent: 0pt"> </td> <td style="padding: 0pt; font-size: 10pt; text-indent: 0pt"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding: 0pt; font-size: 10pt; text-align: center; text-indent: 0pt"> For the year ended December 31, 2025</td> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding: 0pt; font-size: 10pt; text-indent: 0pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt"> </td> <td style="font-size: 10pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; font-size: 10pt">Balance as of January 1,</td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td id="xdx_984_eifrs-full--WarrantLiability_iS_pn3n3_c20260101__20260630_zcqroB8tmnWh" style="width: 12%; font-size: 10pt; text-align: right" title="Balance as of January 1">14,656</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td id="xdx_980_eifrs-full--WarrantLiability_iS_pn3n3_c20250101__20251231_zhFTvn5dQPva" style="width: 12%; font-size: 10pt; text-align: right" title="Balance as of January 1">— </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Investment in financial instruments</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_987_ecustom--InvestmentInFinancialInstruments_pn3n3_c20260101__20260630_zUQMOBRP6izj" style="font-size: 10pt; text-align: right" title="Investment in financial instruments">10,125</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_98A_ecustom--InvestmentInFinancialInstruments_pn3n3_c20250101__20251231_zhwJAC8zRS1c" style="font-size: 10pt; text-align: right" title="Investment in financial instruments">14,494</td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Gain from remeasurement to fair value through profit or loss</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_98C_ecustom--GainFromRevaluationToFairValueThroughProfitOrLoss_pn3n3_c20260101__20260630_zmhKxwVBaBY1" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Gain from revaluation to fair value through profit or loss">219</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_98F_ecustom--GainFromRevaluationToFairValueThroughProfitOrLoss_pn3n3_c20250101__20251231_zxwvghckkS66" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Gain from revaluation to fair value through profit or loss">162</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Balance as of the end of the period</td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td id="xdx_982_eifrs-full--WarrantLiability_iE_pn3n3_c20260101__20260630_zo0W8gm6hukf" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Balance as of January 1">25,000</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td id="xdx_98E_eifrs-full--WarrantLiability_iE_pn3n3_c20250101__20251231_zHgMFbzMtr77" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Balance as of January 1">14,656</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0; margin-bottom: 8pt"> <tr style="vertical-align: top"> <td style="width: 53.85pt"></td> <td style="width: 17.85pt">1.</td> <td style="text-align: justify">Further to Note 12(d) to the Company’s annual consolidated financial statements as of December 31, 2025, on March 23, 2026, the Company completed the second investment in Neurolief in the form of a $6 million convertible loan, following the achievement of the applicable FDA approval milestone.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0; margin-bottom: 8pt"> <tr style="vertical-align: top"> <td style="width: 53.85pt"></td> <td style="width: 17.85pt">1.</td> <td style="text-align: justify">Further to Note 12(d) to the Company's annual consolidated financial statements as of December 31, 2025, on March 12, 2026, the Group made an additional $1.0 million investment pursuant to the original purchase agreement. Following this investment, the Group's aggregate holding represents approximately 37.55% on a fully diluted basis.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0; margin-bottom: 0"> <tr style="vertical-align: top"> <td style="width: 0.75in"></td> <td style="width: 0.25in">2.</td> <td style="text-align: justify">Further to Note 12(d) to the Company's annual consolidated financial statements as of December 31, 2025, after the reporting date, the first milestone was achieved, and on August 26, 2026, the Group made an additional investment of $833 pursuant to the agreement. Following this investment, the Group's aggregate holding represents approximately 14.74% on a fully diluted basis.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0; margin-bottom: 0"> <tr style="vertical-align: top"> <td style="width: 0.75in"></td> <td style="width: 0.25in">3.</td> <td style="text-align: justify">On May 12, 2026, the Group entered into an equity financing agreement with APS Innovations LLC, the parent company of Advanced Psychiatric Management LLC, a management services organization servicing multiple mental health clinics in the greater Chicago area (collectively, "Hopemark Health" or "Hopemark"). Under the terms of the agreement, the Group made an initial investment of $1.5 million, with potential for an additional $1.5 million via milestone-based investments, for a minority position in Hopemark in the form of a preferred, annually compounding security, representing approximately 6.4% on a fully diluted basis in respect of the initial investment. The preferred security accrues an annual return of 8%, compounded annually. The agreement also provides the Group with a redemption right pursuant to which it may require the repurchase of its shares, subject to the terms of the agreement.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0; margin-bottom: 0"> <tr style="vertical-align: top"> <td style="width: 0.75in"></td> <td style="width: 0.25in">4.</td> <td style="text-align: justify">On February 18, 2026, the Group entered into an equity financing agreement with BrainStim Health Inc. ("BrainStim"), under which it made an initial investment of $1.0 million for a minority position in BrainStim in the form of a preferred, 8% annually compounding security, representing approximately 3.66% on a fully diluted basis, with potential for an additional $1.5 million via two milestone-based investments. The BrainStim agreement also provides for one-year put and call options commencing three years from consummation of the transaction at a price based on a minimum return on the investment. The Group is entitled to appoint an observer to BrainStim's board as long as the Group holds a certain minimum number or percentage of stock and was granted certain customary minority veto rights, as well as dividend preference and liquidation preference rights.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0; margin-bottom: 0"> <tr style="vertical-align: top"> <td style="width: 0.75in"></td> <td style="width: 0.25in">5.</td> <td style="text-align: justify">On January 22, 2026, the Group provided a $0.5 million convertible loan to Active Recovery TMS, LLC, a U.S.-based company operating in the mental health services sector. The loan is automatically convertible into the most senior class of preferred units issued in a qualified financing of at least $2.0 million, subject to the terms and conditions of the agreement. As no qualified financing was consummated by June 30, 2026, the loan bears interest at an annual rate of 6% commencing July 1, 2026. Unless earlier converted or the occurrence of any event of default, the outstanding principal and accrued interest will become due and payable on the second anniversary of the note.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0; margin-bottom: 0"> <tr style="vertical-align: top"> <td style="width: 0.75in"></td> <td style="width: 0.25in">6.</td> <td style="text-align: justify">On October 20, 2025, the Group made an initial investment of $125 in Radial Health, Inc. ("Radial") in exchange for 42,580 Series A-1 Preferred Shares, followed by an additional investment of $125 on June 17, 2026 in exchange for 22,317 Series A-2 Preferred Shares, representing in the aggregate approximately 0.21% on a fully diluted basis as of June 30, 2026. Subsequent to the reporting date, the Group completed a further investment of $3,000 on July 15, 2026, in exchange for 535,628 Series A-2 Preferred Shares, increasing the Group's aggregate holding to approximately 1.92% on a fully diluted basis.</td></tr> </table>

<table cellpadding="0" cellspacing="0" id="xdx_89F_eifrs-full--DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory_pn3n3_zDYXxgkq9mZ9" style="border-collapse: collapse; width: 95%; margin-left: 24.95pt" summary="xdx: Disclosure - FINANCIAL INSTRUMENTS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Schedule of Financial instruments measured at fair value</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_497_20260630__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--Level2Member_zbnzgb3GtRw1" style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_494_20260630__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--Leve3Member_zqvo5rvBV6Gd" style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_49E_20251231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--Level2Member__ifrs-full--LevelsOfFairValueHierarchyAxis__custom--FairValueOfHierachyMember_zgNYjRYujxPk" style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_491_20251231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--Level3Member__ifrs-full--LevelsOfFairValueHierarchyAxis__custom--FairValueOfHierachyMember_zpBFoLKo04xd" style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt; text-align: center"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt; text-align: center"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt"> </td> <td colspan="6" style="font-size: 10pt; text-align: center">Fair value hierarchy</td> <td style="font-size: 10pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">June 30, 2026</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">December 31, 2025</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Level 2</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Level 3</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Level 2</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Level 3</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"> </td></tr> <tr id="xdx_408_eifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossAbstract_iB_z3VAXZf8ecxf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Assets measured at fair value:</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_40A_eifrs-full--CurrentDerivativeFinancialAssets_iI_zMeDKRzJDKga" style="vertical-align: bottom; background-color: White"> <td style="width: 48%; font-size: 10pt; text-align: left">Derivative financial instruments (a)</td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 10%; font-size: 10pt; text-align: right">1,060</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 10%; font-size: 10pt; text-align: right"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 10%; font-size: 10pt; text-align: right">1,432</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 10%; font-size: 10pt; text-align: right"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--InvestmentsInFinancialAssetsMeasuredAtFairValueThroughProfitAndLossB_iI_zYFjw4L5EHRb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Investments in financial assets measured at fair value through profit and loss (b)</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">25,000</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">14,656</td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_408_ecustom--FinancialLiabilityMeasuredAtFairValueThroughProfitAndLoss_iI_zxUoy85TRGy6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Financial liability measured at fair value through profit and loss</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">240</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">319</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td></tr> </table>

1060000

1432000

25000000 14656000 240000 319000

646000

1443000

<table cellpadding="0" cellspacing="0" id="xdx_892_eifrs-full--DisclosureOfFinancialInstrumentsDesignatedAtFairValueThroughProfitOrLossExplanatory_zSS3ivV9sIN4" style="border-collapse: collapse; width: 95%; margin-left: 24.95pt" summary="xdx: Disclosure - FINANCIAL INSTRUMENTS (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-indent: -8.5pt; padding-left: 8.5pt">Schedule of  financial instruments are measured at fair value through profit or loss</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">June 30,</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">December 31,</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2026</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2025</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: -8.5pt; padding-left: 8.5pt">Financial assets at fair value through profit or loss:</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-indent: -8.5pt; padding-left: 8.5pt"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; font-size: 10pt; text-indent: -8.5pt; padding-left: 8.5pt">Neurolief (1)</td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td id="xdx_980_eifrs-full--FinancialAssetsAtFairValueThroughProfitOrLoss_iI_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--NeuroliefMember_zGGs286D1nKh" style="width: 12%; font-size: 10pt; text-align: right" title="Financial assets at fair value through profit or loss">11,452</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td id="xdx_984_eifrs-full--FinancialAssetsAtFairValueThroughProfitOrLoss_iI_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--NeuroliefMember_z8TSN5poQYQa" style="width: 12%; font-size: 10pt; text-align: right" title="Financial assets at fair value through profit or loss">5,366</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-indent: -8.5pt; padding-left: 8.5pt">Stella</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_983_eifrs-full--FinancialAssetsAtFairValueThroughProfitOrLoss_iI_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--StellaMember_zzu9KlCNO2la" style="font-size: 10pt; text-align: right" title="Financial assets at fair value through profit or loss">5,631</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_988_eifrs-full--FinancialAssetsAtFairValueThroughProfitOrLoss_iI_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--StellaMember_zMHUrLs8YjKl" style="font-size: 10pt; text-align: right" title="Financial assets at fair value through profit or loss">5,000</td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-indent: -8.5pt; padding-left: 8.5pt">Axis (2)</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_987_eifrs-full--FinancialAssetsAtFairValueThroughProfitOrLoss_iI_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AxisMember_zBqdNgrpMzl5" style="font-size: 10pt; text-align: right" title="Financial assets at fair value through profit or loss">2,608</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_985_eifrs-full--FinancialAssetsAtFairValueThroughProfitOrLoss_iI_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AxisMember_zUYmLbm3Wvtb" style="font-size: 10pt; text-align: right" title="Financial assets at fair value through profit or loss">2,377</td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-indent: -8.5pt; padding-left: 8.5pt">Tangient (3)</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_986_eifrs-full--FinancialAssetsAtFairValueThroughProfitOrLoss_iI_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TangientMember_zZBalP6FjvBg" style="font-size: 10pt; text-align: right" title="Financial assets at fair value through profit or loss">1,713</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_98D_eifrs-full--FinancialAssetsAtFairValueThroughProfitOrLoss_iI_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TangientMember_zqByNSzGblde" style="font-size: 10pt; text-align: right" title="Financial assets at fair value through profit or loss">1,538</td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-indent: -8.5pt; padding-left: 8.5pt">Hopemark (4)</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_985_eifrs-full--FinancialAssetsAtFairValueThroughProfitOrLoss_iI_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--HopemarkMember_zPPrdB466j84" style="font-size: 10pt; text-align: right" title="Financial assets at fair value through profit or loss">1,515</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_980_eifrs-full--FinancialAssetsAtFairValueThroughProfitOrLoss_iI_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--HopemarkMember_z3QEGnvwbWU3" style="font-size: 10pt; text-align: right" title="Financial assets at fair value through profit or loss">— </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-indent: -8.5pt; padding-left: 8.5pt">BrainStim (5)</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_989_eifrs-full--FinancialAssetsAtFairValueThroughProfitOrLoss_iI_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BrainStimMember_zOWf3fuzwWMl" style="font-size: 10pt; text-align: right" title="Financial assets at fair value through profit or loss">1,063</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_980_eifrs-full--FinancialAssetsAtFairValueThroughProfitOrLoss_iI_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BrainStimMember_zycambNI0N7i" style="font-size: 10pt; text-align: right" title="Financial assets at fair value through profit or loss">— </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: -8.5pt; padding-left: 8.5pt">Active Recovery (6)</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_985_eifrs-full--FinancialAssetsAtFairValueThroughProfitOrLoss_iI_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ActiveRecoveryMember_zKxBMwsSAcZ5" style="font-size: 10pt; text-align: right" title="Financial assets at fair value through profit or loss">500</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_983_eifrs-full--FinancialAssetsAtFairValueThroughProfitOrLoss_iI_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ActiveRecoveryMember_z2DYC06sF2m2" style="font-size: 10pt; text-align: right" title="Financial assets at fair value through profit or loss">— </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-indent: -8.5pt; padding-left: 8.5pt">DGR</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_980_eifrs-full--FinancialAssetsAtFairValueThroughProfitOrLoss_iI_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DGRMember_z19qigSocDtj" style="font-size: 10pt; text-align: right" title="Financial assets at fair value through profit or loss">268</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_98C_eifrs-full--FinancialAssetsAtFairValueThroughProfitOrLoss_iI_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DGRMember_zqgD1uJamqHf" style="font-size: 10pt; text-align: right" title="Financial assets at fair value through profit or loss">250</td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 1pt; text-indent: -8.5pt; padding-left: 8.5pt">Radial (7)</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_98F_eifrs-full--FinancialAssetsAtFairValueThroughProfitOrLoss_iI_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--RadialMember_zPAup9q5XXnl" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Financial assets at fair value through profit or loss">250</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_984_eifrs-full--FinancialAssetsAtFairValueThroughProfitOrLoss_iI_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--RadialMember_zMXymnNefnA7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Financial assets at fair value through profit or loss">125</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-indent: -8.5pt; padding-left: 8.5pt"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -8.5pt; padding-left: 8.5pt">Total financial assets at fair value through profit or loss</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_98B_eifrs-full--FinancialAssetsAtFairValueThroughProfitOrLoss_iI_c20260630_zDydJgoTz9Yh" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Financial assets at fair value through profit or loss">25,000</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_983_eifrs-full--FinancialAssetsAtFairValueThroughProfitOrLoss_iI_c20251231_z11MbzeHRd3l" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Financial assets at fair value through profit or loss">14,656</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-indent: -8.5pt; padding-left: 8.5pt"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: -8.5pt; padding-left: 8.5pt">Financial liabilities at fair value through profit or loss:</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-indent: -8.5pt; padding-left: 8.5pt"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 1pt; text-indent: -8.5pt; padding-left: 8.5pt">Neurolief (1)</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_983_eifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLoss_iNI_di_c20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--NeuroliefMember_zYTgMVB6nP8l" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="financial liabilities at fair value through profit or loss">(240</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_984_eifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLoss_iNI_di_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--NeuroliefMember_zhl0geMGwsx6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="financial liabilities at fair value through profit or loss">(319</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-indent: -8.5pt; padding-left: 8.5pt"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -8.5pt; padding-left: 8.5pt">Total financial liabilities at fair value through profit or loss</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_98B_eifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLoss_iNI_di_c20260630_zC4Vm27OVLi7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="financial liabilities at fair value through profit or loss">(240</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_989_eifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLoss_iNI_di_c20251231_zXcQhXTJ8Izj" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="financial liabilities at fair value through profit or loss">(319</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td></tr> </table>

11452000

5366000

5631000

5000000

2608000

2377000

1713000

1538000

1515000

1063000

500000

268000

250000

125000

25000000

14656000

240000

319000

240000

319000

<table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--DisclosureOfWarrantsLiabilityExplanatory_pn3n3_zR7XctkeVto5" style="border-collapse: collapse; width: 95%; margin-left: 24.95pt" summary="xdx: Disclosure - FINANCIAL INSTRUMENTS (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right" title="Investment in financial instruments"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right" title="Investment in financial instruments"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt; font-size: 10pt; text-indent: 0pt"> </td> <td style="padding: 0pt; font-size: 10pt; text-indent: 0pt"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding: 0pt; font-size: 10pt; text-align: center; text-indent: 0pt"> For the six months ended June 30, 2026</td> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding: 0pt; font-size: 10pt; text-indent: 0pt"> </td> <td style="padding: 0pt; font-size: 10pt; text-indent: 0pt"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding: 0pt; font-size: 10pt; text-align: center; text-indent: 0pt"> For the year ended December 31, 2025</td> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding: 0pt; font-size: 10pt; text-indent: 0pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt"> </td> <td style="font-size: 10pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; font-size: 10pt">Balance as of January 1,</td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td id="xdx_984_eifrs-full--WarrantLiability_iS_pn3n3_c20260101__20260630_zcqroB8tmnWh" style="width: 12%; font-size: 10pt; text-align: right" title="Balance as of January 1">14,656</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td id="xdx_980_eifrs-full--WarrantLiability_iS_pn3n3_c20250101__20251231_zhFTvn5dQPva" style="width: 12%; font-size: 10pt; text-align: right" title="Balance as of January 1">— </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Investment in financial instruments</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_987_ecustom--InvestmentInFinancialInstruments_pn3n3_c20260101__20260630_zUQMOBRP6izj" style="font-size: 10pt; text-align: right" title="Investment in financial instruments">10,125</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_98A_ecustom--InvestmentInFinancialInstruments_pn3n3_c20250101__20251231_zhwJAC8zRS1c" style="font-size: 10pt; text-align: right" title="Investment in financial instruments">14,494</td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Gain from remeasurement to fair value through profit or loss</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_98C_ecustom--GainFromRevaluationToFairValueThroughProfitOrLoss_pn3n3_c20260101__20260630_zmhKxwVBaBY1" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Gain from revaluation to fair value through profit or loss">219</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_98F_ecustom--GainFromRevaluationToFairValueThroughProfitOrLoss_pn3n3_c20250101__20251231_zxwvghckkS66" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Gain from revaluation to fair value through profit or loss">162</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Balance as of the end of the period</td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td id="xdx_982_eifrs-full--WarrantLiability_iE_pn3n3_c20260101__20260630_zo0W8gm6hukf" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Balance as of January 1">25,000</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td id="xdx_98E_eifrs-full--WarrantLiability_iE_pn3n3_c20250101__20251231_zHgMFbzMtr77" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Balance as of January 1">14,656</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td></tr> </table>

14656000

10125000 14494000 219000 162000

25000000

14656000

NOTE 6: CONTINGENT LIABILITIES, COMMITMENTS AND CHARGES During the six months ended June 30, 2026, the Company repaid approximately $845 in respect of refundable projects through royalties to the Israeli Government for participation grants in research and development. During this period, no additional grants were received from the government of Israel.

845000 NOTE 7: EQUITY <table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0.05pt; margin-bottom: 0"> <tr style="vertical-align: top"> <td style="width: 24.95pt"></td> <td style="width: 17.65pt">a.</td> <td>Composition of share capital:</td></tr> </table> <table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ScheduleOfClassesOfShareCapitalTableTextBlock_pn3n3_zcjCSfs7y1r6" style="border-collapse: collapse; width: 95%; margin-left: 24.95pt" summary="xdx: Disclosure - EQUITY (Details)"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt">Schedule of composition of share capital</td> <td style="font-size: 10pt"> </td> <td colspan="3" style="font-size: 10pt; text-align: center"> </td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"> </td> <td style="font-size: 10pt"> </td> <td colspan="3" style="font-size: 10pt; text-align: center"> </td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">June 30, 2026</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">December 31, 2025</td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"> Authorized</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Issued and outstanding</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"> Authorized</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Issued and outstanding</td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="15" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Number of shares</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; font-size: 10pt; padding-bottom: 2.5pt">Ordinary shares of NIS 0.04 par value each</td> <td style="width: 1%; font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; font-size: 10pt; text-align: left"> </td> <td id="xdx_981_eifrs-full--NumberOfSharesAuthorised_iI_pip0_c20260630_zYvSpNsBJeNb" style="border-bottom: Black 2.5pt double; width: 12%; font-size: 10pt; text-align: right" title="Number of shares, Authorized">120,000,000</td> <td style="border-bottom: Black 2.5pt double; width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; font-size: 10pt; text-align: left"> </td> <td id="xdx_982_eifrs-full--NumberOfSharesOutstanding_iI_pip0_c20260630_zoQg2akqyjg5" style="border-bottom: Black 2.5pt double; width: 12%; font-size: 10pt; text-align: right" title="Number of shares, Issued and outstanding">40,129,409</td> <td style="border-bottom: Black 2.5pt double; width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; font-size: 10pt; text-align: left"> </td> <td id="xdx_981_eifrs-full--NumberOfSharesAuthorised_iI_pip0_c20251231_zTfRHyIkbmu5" style="border-bottom: Black 2.5pt double; width: 12%; font-size: 10pt; text-align: right" title="Number of shares, Authorized">120,000,000</td> <td style="border-bottom: Black 2.5pt double; width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; font-size: 10pt; text-align: left"> </td> <td id="xdx_986_eifrs-full--NumberOfSharesOutstanding_iI_pip0_c20251231_zgm9Xn80dpqk" style="border-bottom: Black 2.5pt double; width: 12%; font-size: 10pt; text-align: right" title="Number of shares, Issued and outstanding">39,165,805</td> <td style="border-bottom: Black 2.5pt double; width: 1%; font-size: 10pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0.05pt; margin-bottom: 0"> <tr style="vertical-align: top"> <td style="width: 24.95pt"></td> <td style="width: 17.65pt">b.</td> <td>Movement in share capital:</td></tr> </table> <table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--DisclosureOfIssuedAndOutstandingShareCapital_pn3n3_zecP5VpjMYhg" style="border-collapse: collapse; width: 95%; margin-left: 24.95pt" summary="xdx: Disclosure - EQUITY (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">Schedule of issued and outstanding capital</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Number of shares</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">NIS par value</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; font-size: 10pt; text-align: justify">Balance as of January 1, 2026</td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td id="xdx_987_eifrs-full--NumberOfSharesOutstanding_iS_pip0_c20260101__20260630_z89KJmzA3Uy9" style="width: 12%; font-size: 10pt; text-align: right" title="Number of shares, Beginning balance">39,165,805</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td id="xdx_980_ecustom--NumberOfSharesOutstandingValue_iS_pn3n3_c20260101__20260630_zhLt2OWaWjK4" style="width: 12%; font-size: 10pt; text-align: right" title="NIS par value, Beginning balance">1,566,632</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">Vesting of RSU</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_982_ecustom--VestingOfRestrictedSharesShares_pip0_c20260101__20260630_zjXexiCWNO9" style="font-size: 10pt; text-align: right" title="Number of shares, Vesting of restricted shares">60,863</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_989_ecustom--VestingOfRestrictedSharesValue_pn3n3_c20260101__20260630_z9s42e8qiMC1" style="font-size: 10pt; text-align: right" title="NIS par value, Vesting of restricted shares">2,435</td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 1pt">Exercise of share options</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_983_ecustom--ExerciseOfShareOtionsShares_pip0_c20260101__20260630_zRl4AlcTT2M3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Number of shares, Exercise of share options">902,741</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_988_ecustom--ExerciseOfShareOtionsShare_pip0_c20260101__20260630_zIhnDPyTRCk6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Number of shares, Exercise of share options">36,110</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Balance as of June 30, 2026</td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td id="xdx_986_eifrs-full--NumberOfSharesOutstanding_iE_pip0_c20260101__20260630_zxXNP1N5Xed" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Number of shares, Beginning balance">40,129,409</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td id="xdx_983_ecustom--NumberOfSharesOutstandingValue_iE_pn3n3_c20260101__20260630_z8uEjK8LvXAk" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="NIS par value, Beginning balance">1,605,177</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ScheduleOfClassesOfShareCapitalTableTextBlock_pn3n3_zcjCSfs7y1r6" style="border-collapse: collapse; width: 95%; margin-left: 24.95pt" summary="xdx: Disclosure - EQUITY (Details)"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt">Schedule of composition of share capital</td> <td style="font-size: 10pt"> </td> <td colspan="3" style="font-size: 10pt; text-align: center"> </td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"> </td> <td style="font-size: 10pt"> </td> <td colspan="3" style="font-size: 10pt; text-align: center"> </td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">June 30, 2026</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">December 31, 2025</td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"> Authorized</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Issued and outstanding</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"> Authorized</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Issued and outstanding</td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="15" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Number of shares</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; font-size: 10pt; padding-bottom: 2.5pt">Ordinary shares of NIS 0.04 par value each</td> <td style="width: 1%; font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; font-size: 10pt; text-align: left"> </td> <td id="xdx_981_eifrs-full--NumberOfSharesAuthorised_iI_pip0_c20260630_zYvSpNsBJeNb" style="border-bottom: Black 2.5pt double; width: 12%; font-size: 10pt; text-align: right" title="Number of shares, Authorized">120,000,000</td> <td style="border-bottom: Black 2.5pt double; width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; font-size: 10pt; text-align: left"> </td> <td id="xdx_982_eifrs-full--NumberOfSharesOutstanding_iI_pip0_c20260630_zoQg2akqyjg5" style="border-bottom: Black 2.5pt double; width: 12%; font-size: 10pt; text-align: right" title="Number of shares, Issued and outstanding">40,129,409</td> <td style="border-bottom: Black 2.5pt double; width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; font-size: 10pt; text-align: left"> </td> <td id="xdx_981_eifrs-full--NumberOfSharesAuthorised_iI_pip0_c20251231_zTfRHyIkbmu5" style="border-bottom: Black 2.5pt double; width: 12%; font-size: 10pt; text-align: right" title="Number of shares, Authorized">120,000,000</td> <td style="border-bottom: Black 2.5pt double; width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; font-size: 10pt; text-align: left"> </td> <td id="xdx_986_eifrs-full--NumberOfSharesOutstanding_iI_pip0_c20251231_zgm9Xn80dpqk" style="border-bottom: Black 2.5pt double; width: 12%; font-size: 10pt; text-align: right" title="Number of shares, Issued and outstanding">39,165,805</td> <td style="border-bottom: Black 2.5pt double; width: 1%; font-size: 10pt; text-align: left"> </td></tr> </table>

120000000

40129409

120000000

39165805

<table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--DisclosureOfIssuedAndOutstandingShareCapital_pn3n3_zecP5VpjMYhg" style="border-collapse: collapse; width: 95%; margin-left: 24.95pt" summary="xdx: Disclosure - EQUITY (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">Schedule of issued and outstanding capital</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Number of shares</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">NIS par value</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; font-size: 10pt; text-align: justify">Balance as of January 1, 2026</td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td id="xdx_987_eifrs-full--NumberOfSharesOutstanding_iS_pip0_c20260101__20260630_z89KJmzA3Uy9" style="width: 12%; font-size: 10pt; text-align: right" title="Number of shares, Beginning balance">39,165,805</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td id="xdx_980_ecustom--NumberOfSharesOutstandingValue_iS_pn3n3_c20260101__20260630_zhLt2OWaWjK4" style="width: 12%; font-size: 10pt; text-align: right" title="NIS par value, Beginning balance">1,566,632</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">Vesting of RSU</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_982_ecustom--VestingOfRestrictedSharesShares_pip0_c20260101__20260630_zjXexiCWNO9" style="font-size: 10pt; text-align: right" title="Number of shares, Vesting of restricted shares">60,863</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_989_ecustom--VestingOfRestrictedSharesValue_pn3n3_c20260101__20260630_z9s42e8qiMC1" style="font-size: 10pt; text-align: right" title="NIS par value, Vesting of restricted shares">2,435</td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 1pt">Exercise of share options</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_983_ecustom--ExerciseOfShareOtionsShares_pip0_c20260101__20260630_zRl4AlcTT2M3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Number of shares, Exercise of share options">902,741</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_988_ecustom--ExerciseOfShareOtionsShare_pip0_c20260101__20260630_zIhnDPyTRCk6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Number of shares, Exercise of share options">36,110</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Balance as of June 30, 2026</td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td id="xdx_986_eifrs-full--NumberOfSharesOutstanding_iE_pip0_c20260101__20260630_zxXNP1N5Xed" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Number of shares, Beginning balance">40,129,409</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td id="xdx_983_ecustom--NumberOfSharesOutstandingValue_iE_pn3n3_c20260101__20260630_z8uEjK8LvXAk" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="NIS par value, Beginning balance">1,605,177</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td></tr> </table>

39165805

1566632000 60863 2435000 902741 36110

40129409

1605177000

NOTE 8: SHARE BASED PAYMENT <table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0.05pt; margin-bottom: 0"> <tr style="vertical-align: top"> <td style="width: 24.95pt"></td> <td style="width: 17.65pt">a.</td> <td>During the six months periods ended June 30, 2026 and 2025, the Company recorded expenses related to share-based payment plans to employees, directors and consultants of $<span id="xdx_90B_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pn3n3_c20260101__20260630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--DirectorsMember_zGJ9mOIDMxu4" title="Expenses related to share-based payment plans to employees">1,008 and $<span id="xdx_901_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pn3n3_c20260101__20260630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ConsultantsMember_zsDGxRb0L1j" title="Expenses related to share-based payment plans to employees">552, respectively.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0.05pt; margin-bottom: 0"> <tr style="vertical-align: top"> <td style="width: 24.95pt"></td> <td style="width: 17.65pt">b.</td> <td>The following table presents the changes in the number and weighted average exercise prices of share options, and the changes in the number of restricted shares:</td></tr> </table> <table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--DisclosureOfDetailedInformationSharebasedPaymentMovementExplanatory_pn3n3_zaK9fmEH09sb" style="border-collapse: collapse; width: 95%; margin-left: 24.95pt" summary="xdx: Disclosure - SHARE-BASED PAYMENT (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">Schedule of share based payment movement of options</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Options</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Restricted shares</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Total</td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Number of options</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right">Weighted average exercise price (*)</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Number of Restricted shares</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Number of share-based awards</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; font-size: 10pt">Outstanding at January 1, 2026</td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td id="xdx_98D_ecustom--NumberOfOptionOutstandingBalance_iS_pip0_c20260101__20260630_zcsq7yP76NIl" style="width: 12%; font-size: 10pt; text-align: right" title="Number of options, Outstanding at beginning balance">2,229,113</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right">3.41</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td id="xdx_984_ecustom--NumberOfRestrictedSharesOutstandingBalance_iS_pip0_c20260101__20260630_z3WV5YjsDFA5" style="width: 12%; font-size: 10pt; text-align: right" title="Number of Restricted Shares, Outstanding at beginning balance">305,476</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td id="xdx_98F_ecustom--ShareBasedAwardsOutstandingAtBeginningBalance_iS_pip0_c20260101__20260630_zFpbb1WHFDEk" style="width: 12%; font-size: 10pt; text-align: right" title="Total share based awards Outstanding at beginning balance">2,534,589</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">Granted</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_983_ecustom--NumberOfOptionsGranted_pip0_c20260101__20260630_zBD3FnqUiaF6" style="font-size: 10pt; text-align: right" title="Number of options, Granted">75,000</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_986_ecustom--WeightedAverageExercisePriceOfShareOptionsGrantedInSharesBasedPaymentArrangement_pip0_c20260101__20260630_fKCop_zlGut3iX05C5" style="font-size: 10pt; text-align: right" title="Weighted average of exercise price, Granted">10.32</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_987_ecustom--NumberOfRestrictedSharesGranted_pip0_c20260101__20260630_zUbtCUARkZwe" style="font-size: 10pt; text-align: right" title="Number of Restricted Shares, Granted">332,500</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_983_ecustom--NumberOfshareBasedAwardGranted_pip0_c20260101__20260630_zS7Adyntj0n9" style="font-size: 10pt; text-align: right" title="Number ofshare based award, Granted">407,500</td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Exercised</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_980_ecustom--NumberOfOptionsExercised_pip0_c20260101__20260630_zf6ehozUcnYi" style="font-size: 10pt; text-align: right" title="Number of options, Exercised">(902,741</td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_986_ecustom--WeightedAverageExercisePriceOfShareOptionsExercisedInSharesBasedPaymentArrangement_pip0_c20260101__20260630_fKCop_zpAk0ba09cya" style="font-size: 10pt; text-align: right" title="Weighted average of exercise price, Exercised">2.10</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_983_ecustom--NumberOfRestrictedSharesExercised_pip0_c20260101__20260630_zZmXOedIjiFj" style="font-size: 10pt; text-align: right" title="Number of Restricted Shares, Exercised">(60,863</td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_98B_ecustom--NumberOfshareBasedAwardExercised_pip0_c20260101__20260630_zjDXjD1TFXp4" style="font-size: 10pt; text-align: right" title="Number ofshare based award, Exercised">(963,604</td> <td style="font-size: 10pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">Expired</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_989_ecustom--NumberOfOptionsExpired_pip0_c20260101__20260630_zNMUEpgkhvd1" style="font-size: 10pt; text-align: right" title="Number of options, Expired">(228,672</td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_98F_ecustom--WeightedAverageExercisePriceOfShareOptionsExpiredInSharesBasedPaymentArrangement_pip0_c20260101__20260630_fKCop_zo4zogHTI7Ok" style="font-size: 10pt; text-align: right" title="Weighted average of exercise price, Expired">3.73</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_98E_ecustom--NumberOfRestrictedSharesExpired_pip0_c20260101__20260630_zjiOiJoFcZH3" style="font-size: 10pt; text-align: right" title="Number of Restricted Shares, Expired">— </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_98C_ecustom--NumberOfshareBasedAwardExpired_pip0_c20260101__20260630_zAZi2V5DC79d" style="font-size: 10pt; text-align: right" title="Number ofshare based award, Expired">(228,672</td> <td style="font-size: 10pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 1pt">Forfeited</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_98B_ecustom--NumberOfOptionsForfeited_pip0_c20260101__20260630_zHKUtHQVm6M7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Number of options, Forfeited">(89,375</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_986_ecustom--WeightedAverageExercisePriceOfShareOptionsForfeitedInShareBasedPaymentArrangemen_pip0_c20260101__20260630_fKCop_zL1viFjByhof" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Weighted average of exercise price, Forfeited">4.82</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_98A_ecustom--NumberOfRestrictedSharesForfeited_pip0_c20260101__20260630_zaZbtN5VReC6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Number of Restricted Shares, Forfeited">(5,113</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_98E_ecustom--NumberOfShareBasedAwardForfeited_pip0_c20260101__20260630_z9oDvnOfMBW4" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Number ofshare based award, Forfeited">(94,488</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Outstanding at June 30, 2026</td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td id="xdx_98C_ecustom--NumberOfOptionsOutstandingBalance_iE_pip0_c20260101__20260630_z0HF5IEazVf7" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Number of options, Outstanding at ending balance">1,083,325</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td id="xdx_982_ecustom--WeightedAverageExercisePriceOfShareOptionsOutstandingsInShareBasedPaymentArrangement_iE_pip0_c20260101__20260630_fKCop_zwxSKuqKbR6l" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Weighted average of exercise price, Outstanding at ending balance">4.38</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td id="xdx_98D_ecustom--NumberOfRestrictedSharesOutstandingBalance_iE_pip0_c20260101__20260630_zq5LLH08F8G7" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Number of Restricted Shares, Outstanding at ending balance">572,000</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td id="xdx_982_ecustom--ShareBasedAwardsOutstandingAtBeginningBalance_iE_pip0_c20260101__20260630_zhbqKnQ9SHWh" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Total share based awards Outstanding atEnding balance">1,655,325</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Exercisable at June 30, 2026</td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td id="xdx_987_ecustom--NumberOfOptionsExercisable_pip0_c20260101__20260630_zfXtliumIi98" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Number of options, Exercisable">434,881</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td id="xdx_988_ecustom--WeightedAverageExercisePriceOfShareOptionsExercisableInShareBasedPaymentArrangements_pip0_c20260101__20260630_fKCop_zMTfhY1l5nd3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Weighted average of exercise price, Exercisable">4.09</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td id="xdx_989_ecustom--NumberOfRestrictedSharesExercisable_pip0_c20260101__20260630_zeiKmTkhHQXg" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Number of Restricted Shares, Exercisable">— </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td id="xdx_980_ecustom--NumberOfshareBasedAwardsExercisable_pip0_c20260101__20260630_zEYQl5JTSBC" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Number ofShare based awards, Exercisable">434,881</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td></tr> </table> (*) The exercise price of all options is denominated in NIS and was translated to USD in the table above using the exchange rate as of June 30, 2026. The weighted average fair value of the Company’s options granted for the six months ended June 30, 2026 was estimated at $10.32 using the following assumptions: <table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0; margin-bottom: 0"> <tr style="vertical-align: top"> <td style="width: 27.25pt"></td> <td style="width: 12.55pt">·</td> <td>Expected volatility of 49.90%</td></tr> </table> <table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0; margin-bottom: 0"> <tr style="vertical-align: top"> <td style="width: 27.25pt"></td> <td style="width: 12.55pt">·</td> <td>Risk-free interest rate of 3.83%</td></tr> </table>

1008000

552000

<table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--DisclosureOfDetailedInformationSharebasedPaymentMovementExplanatory_pn3n3_zaK9fmEH09sb" style="border-collapse: collapse; width: 95%; margin-left: 24.95pt" summary="xdx: Disclosure - SHARE-BASED PAYMENT (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">Schedule of share based payment movement of options</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td colspan="3" style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Options</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Restricted shares</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Total</td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Number of options</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right">Weighted average exercise price (*)</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Number of Restricted shares</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Number of share-based awards</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; font-size: 10pt">Outstanding at January 1, 2026</td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td id="xdx_98D_ecustom--NumberOfOptionOutstandingBalance_iS_pip0_c20260101__20260630_zcsq7yP76NIl" style="width: 12%; font-size: 10pt; text-align: right" title="Number of options, Outstanding at beginning balance">2,229,113</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right">3.41</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td id="xdx_984_ecustom--NumberOfRestrictedSharesOutstandingBalance_iS_pip0_c20260101__20260630_z3WV5YjsDFA5" style="width: 12%; font-size: 10pt; text-align: right" title="Number of Restricted Shares, Outstanding at beginning balance">305,476</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td id="xdx_98F_ecustom--ShareBasedAwardsOutstandingAtBeginningBalance_iS_pip0_c20260101__20260630_zFpbb1WHFDEk" style="width: 12%; font-size: 10pt; text-align: right" title="Total share based awards Outstanding at beginning balance">2,534,589</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">Granted</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_983_ecustom--NumberOfOptionsGranted_pip0_c20260101__20260630_zBD3FnqUiaF6" style="font-size: 10pt; text-align: right" title="Number of options, Granted">75,000</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_986_ecustom--WeightedAverageExercisePriceOfShareOptionsGrantedInSharesBasedPaymentArrangement_pip0_c20260101__20260630_fKCop_zlGut3iX05C5" style="font-size: 10pt; text-align: right" title="Weighted average of exercise price, Granted">10.32</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_987_ecustom--NumberOfRestrictedSharesGranted_pip0_c20260101__20260630_zUbtCUARkZwe" style="font-size: 10pt; text-align: right" title="Number of Restricted Shares, Granted">332,500</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_983_ecustom--NumberOfshareBasedAwardGranted_pip0_c20260101__20260630_zS7Adyntj0n9" style="font-size: 10pt; text-align: right" title="Number ofshare based award, Granted">407,500</td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Exercised</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_980_ecustom--NumberOfOptionsExercised_pip0_c20260101__20260630_zf6ehozUcnYi" style="font-size: 10pt; text-align: right" title="Number of options, Exercised">(902,741</td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_986_ecustom--WeightedAverageExercisePriceOfShareOptionsExercisedInSharesBasedPaymentArrangement_pip0_c20260101__20260630_fKCop_zpAk0ba09cya" style="font-size: 10pt; text-align: right" title="Weighted average of exercise price, Exercised">2.10</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_983_ecustom--NumberOfRestrictedSharesExercised_pip0_c20260101__20260630_zZmXOedIjiFj" style="font-size: 10pt; text-align: right" title="Number of Restricted Shares, Exercised">(60,863</td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_98B_ecustom--NumberOfshareBasedAwardExercised_pip0_c20260101__20260630_zjDXjD1TFXp4" style="font-size: 10pt; text-align: right" title="Number ofshare based award, Exercised">(963,604</td> <td style="font-size: 10pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">Expired</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_989_ecustom--NumberOfOptionsExpired_pip0_c20260101__20260630_zNMUEpgkhvd1" style="font-size: 10pt; text-align: right" title="Number of options, Expired">(228,672</td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_98F_ecustom--WeightedAverageExercisePriceOfShareOptionsExpiredInSharesBasedPaymentArrangement_pip0_c20260101__20260630_fKCop_zo4zogHTI7Ok" style="font-size: 10pt; text-align: right" title="Weighted average of exercise price, Expired">3.73</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_98E_ecustom--NumberOfRestrictedSharesExpired_pip0_c20260101__20260630_zjiOiJoFcZH3" style="font-size: 10pt; text-align: right" title="Number of Restricted Shares, Expired">— </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_98C_ecustom--NumberOfshareBasedAwardExpired_pip0_c20260101__20260630_zAZi2V5DC79d" style="font-size: 10pt; text-align: right" title="Number ofshare based award, Expired">(228,672</td> <td style="font-size: 10pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 1pt">Forfeited</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_98B_ecustom--NumberOfOptionsForfeited_pip0_c20260101__20260630_zHKUtHQVm6M7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Number of options, Forfeited">(89,375</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_986_ecustom--WeightedAverageExercisePriceOfShareOptionsForfeitedInShareBasedPaymentArrangemen_pip0_c20260101__20260630_fKCop_zL1viFjByhof" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Weighted average of exercise price, Forfeited">4.82</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_98A_ecustom--NumberOfRestrictedSharesForfeited_pip0_c20260101__20260630_zaZbtN5VReC6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Number of Restricted Shares, Forfeited">(5,113</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_98E_ecustom--NumberOfShareBasedAwardForfeited_pip0_c20260101__20260630_z9oDvnOfMBW4" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Number ofshare based award, Forfeited">(94,488</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Outstanding at June 30, 2026</td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td id="xdx_98C_ecustom--NumberOfOptionsOutstandingBalance_iE_pip0_c20260101__20260630_z0HF5IEazVf7" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Number of options, Outstanding at ending balance">1,083,325</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td id="xdx_982_ecustom--WeightedAverageExercisePriceOfShareOptionsOutstandingsInShareBasedPaymentArrangement_iE_pip0_c20260101__20260630_fKCop_zwxSKuqKbR6l" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Weighted average of exercise price, Outstanding at ending balance">4.38</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td id="xdx_98D_ecustom--NumberOfRestrictedSharesOutstandingBalance_iE_pip0_c20260101__20260630_zq5LLH08F8G7" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Number of Restricted Shares, Outstanding at ending balance">572,000</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td id="xdx_982_ecustom--ShareBasedAwardsOutstandingAtBeginningBalance_iE_pip0_c20260101__20260630_zhbqKnQ9SHWh" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Total share based awards Outstanding atEnding balance">1,655,325</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Exercisable at June 30, 2026</td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td id="xdx_987_ecustom--NumberOfOptionsExercisable_pip0_c20260101__20260630_zfXtliumIi98" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Number of options, Exercisable">434,881</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td id="xdx_988_ecustom--WeightedAverageExercisePriceOfShareOptionsExercisableInShareBasedPaymentArrangements_pip0_c20260101__20260630_fKCop_zMTfhY1l5nd3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Weighted average of exercise price, Exercisable">4.09</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td id="xdx_989_ecustom--NumberOfRestrictedSharesExercisable_pip0_c20260101__20260630_zeiKmTkhHQXg" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Number of Restricted Shares, Exercisable">— </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td id="xdx_980_ecustom--NumberOfshareBasedAwardsExercisable_pip0_c20260101__20260630_zEYQl5JTSBC" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Number ofShare based awards, Exercisable">434,881</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td></tr> </table> (*) The exercise price of all options is denominated in NIS and was translated to USD in the table above using the exchange rate as of June 30, 2026. 2229113 3.41 305476 2534589 75000 10.32 332500 407500 -902741 2.10 -60863 -963604 -228672 3.73 -228672 -89375 4.82 -5113 -94488 1083325 4.38 572000 1655325 434881 4.09 434881 10.32

0.4990

0.0383

NOTE 9: ADDITIONAL INFORMATION TO THE STATEMENTS OF COMPREHENSIVE INCOME <table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0.05pt; margin-bottom: 0"> <tr style="vertical-align: top"> <td style="width: 24.95pt"></td> <td style="width: 17.65pt">a.</td> <td>Revenues:</td></tr> </table> <table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0; margin-bottom: 0"> <tr style="vertical-align: top"> <td style="width: 42.55pt"></td> <td style="width: 17.65pt">1.</td> <td>Revenues reported in the financial statements for each group of similar products and services:</td></tr> </table> <table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--DisclosureOfDetailedInformationAdditionalInformationOnRevenuesExplanatory_pn3n3_zaka3wBg0gDd" style="border-collapse: collapse; width: 95%; margin-left: 24.95pt" summary="xdx: Disclosure - ADDITIONAL INFORMATION TO THE STATEMENTS OF COMPREHENSIVE LOSS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Schedule of additional information on revenues</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_491_20260101__20260630_zbg0LPUYMBZ9" style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_497_20250101__20250630_zDBcp4YqK00h" style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Six months ended June 30,</td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2026</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2025</td></tr> <tr id="xdx_408_ecustom--RevenuesFromSale_zYdKYhrkV4q2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; font-size: 10pt; text-align: left">Revenues from sale</td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right">23,393</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right">15,740</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_409_ecustom--RevenuesFromLease_zFCF3dTNtkG3" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Revenues from lease</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">6,775</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">5,868</td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_400_ecustom--RevenuesFromSaleRelatedService_zwRoJwI1Z981" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Revenues from sale related service</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">1,719</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">2,042</td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_406_ecustom--RevenuesFromOtherService_zGtnpUBPk8pg" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Revenues from other service</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">751</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">518</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_409_eifrs-full--Revenue_i_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Total</td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">32,638</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">24,168</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 7.55pt; margin-bottom: 0"> <tr style="vertical-align: top"> <td style="width: 42.55pt"></td> <td style="width: 17.65pt">2.</td> <td>Revenues from major customers, each accounting for 10% or more of total revenues reported in the financial statements:</td></tr> </table> <table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--DisclosureOfRevenuesFromMajorCustomersExplanatary_pn3n3_zGWWSzIJeIv9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%; margin-left: 24.95pt" summary="xdx: Disclosure - ADDITIONAL INFORMATION TO THE STATEMENTS OF COMPREHENSIVE LOSS (Details 1)"> <tr style="vertical-align: bottom"> <td>Schedule of Revenues from major customers</td> <td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center"> </td> <td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Six months ended June 30,</td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; text-align: left">Customer A</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_98B_ecustom--PercentageOfRevenue_pip0_dp_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CustomerAMember_zjuWRyCEehak" style="width: 12%; text-align: right" title="Revenues, percent">27</td> <td style="width: 1%; text-align: left">%</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_98F_ecustom--PercentageOfRevenue_pip0_dp_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CustomerAMember_zqpWsqTlRu5a" style="width: 12%; text-align: right" title="Revenues, percent">31</td> <td style="width: 1%; text-align: left">%</td></tr> </table> Geographic information: Revenues reported in the financial statements based on the location of the customers are as follows: <table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--DisclosureOfGeographicInformationExplanatary_pn3n3_zpmXtEeX2vnj" style="border-collapse: collapse; width: 95%; margin-left: 24.95pt" summary="xdx: Disclosure - ADDITIONAL INFORMATION TO THE STATEMENTS OF COMPREHENSIVE LOSS (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: justify">Schedule of Geographic information</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify; font-size: 10pt"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td colspan="15" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">Six months ended June 30,</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify; font-size: 10pt"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold">2026</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold">%</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2025</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; font-size: 10pt; text-align: justify">U.S.</td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td id="xdx_989_eifrs-full--Revenue_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CountryOfUSAMember_zuVNR5kFgiQ8" style="width: 12%; font-size: 10pt; text-align: right" title="Revenues">24,237</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 12%; font-size: 10pt; text-align: right">74</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td id="xdx_98C_eifrs-full--Revenue_pn3n3_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CountryOfUSAMember_zdG5jFMP6mIi" style="width: 12%; font-size: 10pt; text-align: right" title="Revenues">20,336</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 12%; font-size: 10pt; text-align: right">84.1</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: justify; padding-bottom: 1pt">APA</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_981_eifrs-full--Revenue_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CountryOfAPAMember_zd0q113LMRha" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues">3,870</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">12</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_986_eifrs-full--Revenue_pn3n3_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CountryOfAPAMember_z05YD6l6JJeb" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues">2,347</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">9.7</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: justify; padding-bottom: 1pt">Other</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_985_eifrs-full--Revenue_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OtherMember_zNpx7ze25rRj" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues">4,531</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">14</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_986_eifrs-full--Revenue_pn3n3_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OtherMember_zWqyqqot1fX6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues">1,485</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">6.2</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: justify; padding-bottom: 2.5pt"> </td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td id="xdx_984_eifrs-full--Revenue_pn3n3_c20260101__20260630_zhYtSUQXxE7h" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues">32,638</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">100</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td id="xdx_98C_eifrs-full--Revenue_pn3n3_c20250101__20250630_z1EYf5UuD4D1" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues">24,168</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">100</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--DisclosureOfDetailedInformationAdditionalInformationOnRevenuesExplanatory_pn3n3_zaka3wBg0gDd" style="border-collapse: collapse; width: 95%; margin-left: 24.95pt" summary="xdx: Disclosure - ADDITIONAL INFORMATION TO THE STATEMENTS OF COMPREHENSIVE LOSS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Schedule of additional information on revenues</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_491_20260101__20260630_zbg0LPUYMBZ9" style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_497_20250101__20250630_zDBcp4YqK00h" style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Six months ended June 30,</td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2026</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2025</td></tr> <tr id="xdx_408_ecustom--RevenuesFromSale_zYdKYhrkV4q2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; font-size: 10pt; text-align: left">Revenues from sale</td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right">23,393</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right">15,740</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_409_ecustom--RevenuesFromLease_zFCF3dTNtkG3" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Revenues from lease</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">6,775</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">5,868</td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_400_ecustom--RevenuesFromSaleRelatedService_zwRoJwI1Z981" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Revenues from sale related service</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">1,719</td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right">2,042</td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_406_ecustom--RevenuesFromOtherService_zGtnpUBPk8pg" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Revenues from other service</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">751</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">518</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_409_eifrs-full--Revenue_i_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Total</td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">32,638</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">24,168</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td></tr> </table> 23393000 15740000 6775000 5868000 1719000 2042000 751000 518000

32638000

24168000

<table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--DisclosureOfRevenuesFromMajorCustomersExplanatary_pn3n3_zGWWSzIJeIv9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%; margin-left: 24.95pt" summary="xdx: Disclosure - ADDITIONAL INFORMATION TO THE STATEMENTS OF COMPREHENSIVE LOSS (Details 1)"> <tr style="vertical-align: bottom"> <td>Schedule of Revenues from major customers</td> <td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center"> </td> <td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Six months ended June 30,</td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; text-align: left">Customer A</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_98B_ecustom--PercentageOfRevenue_pip0_dp_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CustomerAMember_zjuWRyCEehak" style="width: 12%; text-align: right" title="Revenues, percent">27</td> <td style="width: 1%; text-align: left">%</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_98F_ecustom--PercentageOfRevenue_pip0_dp_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CustomerAMember_zqpWsqTlRu5a" style="width: 12%; text-align: right" title="Revenues, percent">31</td> <td style="width: 1%; text-align: left">%</td></tr> </table> 0.27 0.31 <table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--DisclosureOfGeographicInformationExplanatary_pn3n3_zpmXtEeX2vnj" style="border-collapse: collapse; width: 95%; margin-left: 24.95pt" summary="xdx: Disclosure - ADDITIONAL INFORMATION TO THE STATEMENTS OF COMPREHENSIVE LOSS (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: justify">Schedule of Geographic information</td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify; font-size: 10pt"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td colspan="15" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">Six months ended June 30,</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify; font-size: 10pt"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold">2026</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold">%</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2025</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; font-size: 10pt; text-align: justify">U.S.</td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td id="xdx_989_eifrs-full--Revenue_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CountryOfUSAMember_zuVNR5kFgiQ8" style="width: 12%; font-size: 10pt; text-align: right" title="Revenues">24,237</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 12%; font-size: 10pt; text-align: right">74</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td id="xdx_98C_eifrs-full--Revenue_pn3n3_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CountryOfUSAMember_zdG5jFMP6mIi" style="width: 12%; font-size: 10pt; text-align: right" title="Revenues">20,336</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 12%; font-size: 10pt; text-align: right">84.1</td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: justify; padding-bottom: 1pt">APA</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_981_eifrs-full--Revenue_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CountryOfAPAMember_zd0q113LMRha" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues">3,870</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">12</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_986_eifrs-full--Revenue_pn3n3_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CountryOfAPAMember_z05YD6l6JJeb" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues">2,347</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">9.7</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: justify; padding-bottom: 1pt">Other</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_985_eifrs-full--Revenue_pn3n3_c20260101__20260630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OtherMember_zNpx7ze25rRj" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues">4,531</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">14</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_986_eifrs-full--Revenue_pn3n3_c20250101__20250630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--OtherMember_zWqyqqot1fX6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues">1,485</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">6.2</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: justify; padding-bottom: 2.5pt"> </td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td id="xdx_984_eifrs-full--Revenue_pn3n3_c20260101__20260630_zhYtSUQXxE7h" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues">32,638</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">100</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td id="xdx_98C_eifrs-full--Revenue_pn3n3_c20250101__20250630_z1EYf5UuD4D1" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues">24,168</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">100</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td></tr> </table>

24237000

0.74

20336000

0.841

3870000

0.12

2347000

0.097

4531000

0.14

1485000

0.062

32638000

24168000

NOTE 10: EARNINGS PER SHARE Number of shares and profit used in the computation of basic and diluted earnings per share: <table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--DisclosureOfDetailedInformationEarningsPerShareExplanatary_pn3n3_zwKmBvM802Ol" style="border-collapse: collapse; width: 95%; margin-left: 24.95pt" summary="xdx: Disclosure - NET INCOME (LOSS) PER SHARE (Details)"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt">Schedule of net loss per share</td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="text-align: center; font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"> </td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="text-align: center; font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="15" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Six months ended June 30,</td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2026</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2025</td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="text-align: center; font-size: 10pt; font-weight: bold"> Weighted number of shares</td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"> Profit attributable to equity holders of the Company</td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="text-align: center; font-size: 10pt; font-weight: bold"> Weighted number of shares</td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"> Profit attributable to equity holders of the Company</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; font-size: 10pt; text-align: left; padding-bottom: 1pt">For the computation of basic earnings per share</td> <td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"> </td> <td id="xdx_982_eifrs-full--WeightedAverageShares_pid_c20260101__20260630_fKik___zF50DvhI1bkh" style="border-bottom: Black 1pt solid; width: 12%; font-size: 10pt; text-align: right" title="Weighted number of shares">39,372,417</td> <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left">$</td> <td id="xdx_989_eifrs-full--ProfitLoss_pn3n3_c20260101__20260630_zUYBvq9Udv03" style="border-bottom: Black 1pt solid; width: 12%; font-size: 10pt; text-align: right" title="Loss attributable to equity holders of the Company">5,000</td> <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"> </td> <td id="xdx_98D_eifrs-full--WeightedAverageShares_pid_c20250101__20250630_fKik___zlcmIhrdJiVf" style="border-bottom: Black 1pt solid; width: 12%; font-size: 10pt; text-align: right" title="Weighted number of shares">37,705,678</td> <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left">$</td> <td id="xdx_980_eifrs-full--ProfitLoss_pn3n3_c20250101__20250630_z07LdEZyPB46" style="border-bottom: Black 1pt solid; width: 12%; font-size: 10pt; text-align: right" title="Loss attributable to equity holders of the Company">3,134</td> <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Effect of potential dilutive ordinary shares</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_987_eifrs-full--DilutiveEffectOfAllInstrumentsOnWeightedAverageNumberOfOrdinaryShares_pid_c20260101__20260630_fKik___zaHpbWaDHAea" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Weighted number of shares">1,627,955</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_980_eifrs-full--ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_pn3n3_c20260101__20260630_z8itJB1JlnB4" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Effect of potential dilutive ordinary shares">— </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_989_eifrs-full--DilutiveEffectOfAllInstrumentsOnWeightedAverageNumberOfOrdinaryShares_pid_c20250101__20250630_fKik___zNnU2Wvp29Y2" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Weighted number of shares">1,356,991</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_989_eifrs-full--ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_pn3n3_c20250101__20250630_zMvGWtiMeQV7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Effect of potential dilutive ordinary shares">(303</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">For the computation of diluted earnings per share</td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td id="xdx_98A_ecustom--WeightedAverageSharesBasicAndDilutedNetProfit_pid_c20260101__20260630_fKik___z5JIAthXbbxa" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Weighted number of shares">41,000,372</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td id="xdx_986_ecustom--ProfitLossBasicAndDilutedNetProfit_iN_pn3n3_di_c20260101__20260630_zQowap3Gn0Z3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Loss attributable to equity holders of the Company">5,000</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td id="xdx_98C_ecustom--WeightedAverageSharesBasicAndDilutedNetProfit_pid_c20250101__20250630_fKik___zVTBlAZXbTCe" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Weighted number of shares">39,062,669</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td id="xdx_98A_ecustom--ProfitLossBasicAndDilutedNetProfit_iN_pn3n3_di_c20250101__20250630_zFBZruOZatki" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Loss attributable to equity holders of the Company">2,831</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td></tr> </table>

<table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--DisclosureOfDetailedInformationEarningsPerShareExplanatary_pn3n3_zwKmBvM802Ol" style="border-collapse: collapse; width: 95%; margin-left: 24.95pt" summary="xdx: Disclosure - NET INCOME (LOSS) PER SHARE (Details)"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt">Schedule of net loss per share</td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="text-align: center; font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"> </td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="text-align: center; font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="15" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Six months ended June 30,</td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2026</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2025</td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="text-align: center; font-size: 10pt; font-weight: bold"> Weighted number of shares</td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"> Profit attributable to equity holders of the Company</td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="text-align: center; font-size: 10pt; font-weight: bold"> Weighted number of shares</td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"> Profit attributable to equity holders of the Company</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; font-size: 10pt; text-align: left; padding-bottom: 1pt">For the computation of basic earnings per share</td> <td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"> </td> <td id="xdx_982_eifrs-full--WeightedAverageShares_pid_c20260101__20260630_fKik___zF50DvhI1bkh" style="border-bottom: Black 1pt solid; width: 12%; font-size: 10pt; text-align: right" title="Weighted number of shares">39,372,417</td> <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left">$</td> <td id="xdx_989_eifrs-full--ProfitLoss_pn3n3_c20260101__20260630_zUYBvq9Udv03" style="border-bottom: Black 1pt solid; width: 12%; font-size: 10pt; text-align: right" title="Loss attributable to equity holders of the Company">5,000</td> <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"> </td> <td id="xdx_98D_eifrs-full--WeightedAverageShares_pid_c20250101__20250630_fKik___zlcmIhrdJiVf" style="border-bottom: Black 1pt solid; width: 12%; font-size: 10pt; text-align: right" title="Weighted number of shares">37,705,678</td> <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"> </td> <td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left">$</td> <td id="xdx_980_eifrs-full--ProfitLoss_pn3n3_c20250101__20250630_z07LdEZyPB46" style="border-bottom: Black 1pt solid; width: 12%; font-size: 10pt; text-align: right" title="Loss attributable to equity holders of the Company">3,134</td> <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Effect of potential dilutive ordinary shares</td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_987_eifrs-full--DilutiveEffectOfAllInstrumentsOnWeightedAverageNumberOfOrdinaryShares_pid_c20260101__20260630_fKik___zaHpbWaDHAea" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Weighted number of shares">1,627,955</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_980_eifrs-full--ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_pn3n3_c20260101__20260630_z8itJB1JlnB4" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Effect of potential dilutive ordinary shares">— </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_989_eifrs-full--DilutiveEffectOfAllInstrumentsOnWeightedAverageNumberOfOrdinaryShares_pid_c20250101__20250630_fKik___zNnU2Wvp29Y2" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Weighted number of shares">1,356,991</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td> <td id="xdx_989_eifrs-full--ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_pn3n3_c20250101__20250630_zMvGWtiMeQV7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Effect of potential dilutive ordinary shares">(303</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">For the computation of diluted earnings per share</td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td id="xdx_98A_ecustom--WeightedAverageSharesBasicAndDilutedNetProfit_pid_c20260101__20260630_fKik___z5JIAthXbbxa" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Weighted number of shares">41,000,372</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td id="xdx_986_ecustom--ProfitLossBasicAndDilutedNetProfit_iN_pn3n3_di_c20260101__20260630_zQowap3Gn0Z3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Loss attributable to equity holders of the Company">5,000</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td id="xdx_98C_ecustom--WeightedAverageSharesBasicAndDilutedNetProfit_pid_c20250101__20250630_fKik___zVTBlAZXbTCe" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Weighted number of shares">39,062,669</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td id="xdx_98A_ecustom--ProfitLossBasicAndDilutedNetProfit_iN_pn3n3_di_c20250101__20250630_zFBZruOZatki" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Loss attributable to equity holders of the Company">2,831</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td></tr> </table>

39372417

5000000

37705678

3134000

1627955

1356991

-303000

41000372 -5000000 39062669 -2831000

NOTE 11: RELATED AND INTERESTED PARTIES During the six-month period ended June 30, 2026, the Group recognized revenues of $70 and $140 from two clinics (Clinic A and B, respectively) that are serviced by management services organizations in which Tikva holds minority investments. As an accounting matter, including due to influence considerations, we will be treating these entities as related parties, although the investment contract terms are unrelated to the revenue-generating contracts, and although the investment and revenue-generating agreements are with different Group entities. As of June 30, 2026, the trade receivable balances amounted to $135 from Clinic A. The investments in these entities are measured at fair value through profit or loss in accordance with IFRS 9.

70000

140000

135000

NOTE 12: SUBSEQUENT EVENTS <table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0.1pt; margin-bottom: 0"> <tr style="vertical-align: top"> <td style="width: 27.3pt"></td> <td style="width: 12.6pt">1.</td> <td style="text-align: justify">On July 14, 2026, the Company made a strategic minority equity investment of $3.0 million in Radial, a management services organization supporting a network of Brain Medicine clinics. The investment was made as part of Radial’s Series A financing round and is consistent with the Company’s strategy to secure minority equity positions in mental health provider networks. For more information see Note 5.B.7.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0; margin-bottom: 0"> <tr style="vertical-align: top"> <td style="width: 27.25pt"></td> <td style="width: 12.6pt">2.</td> <td style="text-align: justify">On July 15, 2026, the Company entered into a strategic equity financing agreement with CM Counsel Management LLC (“Sound Minds”), a behavioral health services provider operating multiple locations in the United States. Under the terms of the agreement, the Company will invest $500 for a minority equity interest in Sound Minds in the form of a preferred, annually compounding security.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0; margin-bottom: 0"> <tr style="vertical-align: top"> <td style="width: 27.25pt"> </td> <td style="width: 12.6pt">3.</td> <td style="text-align: justify">On August 26, 2026, following the achievement of the first milestone under the Series A Preferred Stock Purchase Agreement with Tangient, the Group made an additional milestone investment of approximately $833. For more information see Note 5.B.3.</td></tr> </table> 3000000.0 500000 833000